End of induction MRD assessment based early treatment intensification with novel agents in ETP-ALL- may be the way forward.

Patra, Pritish Chandra; Rainchwar, Sujay; Singh, Reema; Halder, Rohan; Mehta, Pallavi; Verma, Megha; Ahmed, Rayaz; Raichaudhuri, Jyoti Shankar; Bhurani, Dinesh; Agrawal, Narendra; Pramanik, Suman.

Afiliación

Patra PC; Department of Hemato-Oncology and BMT, Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India.
Rainchwar S; Department of Hemato-Oncology and BMT, Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India.
Singh R; Department of Hemato-Oncology and BMT, Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India.
Halder R; Department of Hemato-Oncology and BMT, Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India.
Mehta P; Department of Hemato-Oncology and BMT, Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India.
Verma M; Department of Hemato-Oncology and BMT, Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India.
Ahmed R; Department of Hemato-Oncology and BMT, Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India.
Raichaudhuri JS; Department of Hemato-Oncology and BMT, Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India.
Bhurani D; Department of Hemato-Oncology and BMT, Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India.
Agrawal N; Department of Hemato-Oncology and BMT, Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India.
Pramanik S; Clinical Hematology, Army Hospital, Delhi, India.

Blood Res ; 58(2): 112-115, 2023 Jun 30.

Article en En | MEDLINE | ID: mdl-37160382

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Blood Res Año: 2023 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Blood Res Año: 2023 Tipo del documento: Article